["{\n\"step_by_step_thinking\": \"The patient has type 1 diabetes mellitus, which means the pancreas does not produce enough insulin. Exenatide is a drug that mimics the action of endogenous insulin, but it does not stimulate glucagon secretion. The text also highlights the importance of insulin therapy in maintaining blood glucose levels below 200mg/100ml. Given these facts, the best explanation for why the patient should not be switched to exenatide is that his pancreas is insufficiently producing insulin.\",\n\"answer_choice\": \"A\""]